|NGIs Reporting Area||Indicator Definition||Indicator Level|
|Number of HIV-positive patients in HIV care or treatment (pre-ART or ART) who started TB treatment||PEPFAR Output|
|Health Systems Strengthening|
|Number of testing facilities (laboratories) with capacity to perform clinical laboratory tests||PEPFAR Output|
|Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission||PEPFAR Output|
|Percent of HIV-positive pregnant women who received antiretrovirals to reduce the risk of mother-to-child-transmission||National Outcome|
|Number of individuals who received testing and counseling services for HIV and received their test results||PEPFAR Output|
|Number of adults and children with advanced HIV infection newly enrolled on ART||PEPFAR Output|
|Percent of adults and children with advanced HIV infection receiving antiretroviral therapy||PEPFAR Output|
|Percent of adults and children with advanced HIV infection receiving antiretroviral therapy||National Outcome|
|Percent of adults and children known to be alive and on treatment 12 months after initiation of antiretroviral therapy||PEPFAR Outcome|
NOTE: Indicator level classified according to 2009 Next Generation Indicator Guidance. ART = antiretroviral therapy; NGIs = Next Generation Indicators; TB = tuberculosis.
SOURCES: OGAC, 2005c, 2007f, 2009e.
right to first publication also represented a barrier to data sharing for the evaluation. More information about the PEPFAR-specific data considered, requested, and used by the committee can be found in the more detailed description of the methods in Appendix C. The PEPFAR indicators are also discussed in Chapter 11 on PEPFAR’s knowledge management.